AMN Healthcare Names Mark Foletta as Chairman

Dow Jones

02-08

By Stephen Nakrosis

AMN Healthcare Services said Mark Foletta was named its new chairman of the board.

He succeeds Douglas Wheat, who had served on the board since 1999.

Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals.

Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus Therapeutics and Ambit Biosciences, AMN said Friday.

AMN provides healthcare staffing services and workforce solutions.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

February 07, 2025 16:38 ET (21:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2509790774"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509790774\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2509790774?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-08 05:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509790774","market":"other","top_or_hot":-1,"title":"AMN Healthcare Names Mark Foletta as Chairman","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  AMN Healthcare Services said Mark Foletta was named its new chairman of the board. \n</p>\n<p>\n  He succeeds Douglas Wheat, who had served on the board since 1999. \n</p>\n<p>\n  Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals. \n</p>\n<p>\n  Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Ambit Biosciences, AMN said Friday. \n</p>\n<p>\n  AMN provides healthcare staffing services and workforce solutions. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 07, 2025 16:38 ET (21:38 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMN Healthcare Names Mark Foletta as Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMN Healthcare Names Mark Foletta as Chairman\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-02-08 05:38</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  AMN Healthcare Services said Mark Foletta was named its new chairman of the board. \n</p>\n<p>\n  He succeeds Douglas Wheat, who had served on the board since 1999. \n</p>\n<p>\n  Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals. \n</p>\n<p>\n  Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Ambit Biosciences, AMN said Friday. \n</p>\n<p>\n  AMN provides healthcare staffing services and workforce solutions. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 07, 2025 16:38 ET (21:38 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健護理服務","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2509790774","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509790774","pubTimestamp":1738964280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"AMN Healthcare Services said Mark Foletta was named its new chairman of the board.He succeeds Douglas Wheat, who had served on the board since 1999.Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals.Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus Therapeutics and Ambit Biosciences, AMN said Friday.AMN provides healthcare staffing services and workforce solutions.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","AMN":"AMN医疗服务"},"translate_title":"AMN Healthcare任命Mark Foletta为董事长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMN":1},"content_text":"By Stephen Nakrosis \n\n\n \n\n\n  AMN Healthcare Services said Mark Foletta was named its new chairman of the board. \n\n\n  He succeeds Douglas Wheat, who had served on the board since 1999. \n\n\n  Foletta, who joined the board in 2012, served as vice president and chief financial officer of Tocagen from February 2017 until March 2020. Prior to that, he was interim CFO of Biocept, and SVP, finance and CFO of Amylin Pharmaceuticals. \n\n\n  Foletta currently is on the boards of DexCom and Entanta Pharmaceuticals. He previously served on other company boards, including Regulus Therapeutics and Ambit Biosciences, AMN said Friday. \n\n\n  AMN provides healthcare staffing services and workforce solutions. \n\n\n \n\n\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 07, 2025 16:38 ET (21:38 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1}}}